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Random walk with restartIn humans, despite the rapid increase in disease-associated gene discovery, a large proportion of
disease-associated genes are still unknown. Many network-based approaches have been used to
prioritize disease genes. Many networks, such as the protein–protein interaction (PPI), KEGG, and
gene co-expression networks, have been used. Expression quantitative trait loci (eQTLs) have been
successfully applied for the determination of genes associated with several diseases. In this study,
we constructed an eQTL-based gene–gene co-regulation network (GGCRN) and used it to mine for
disease genes. We adopted the random walk with restart (RWR) algorithm to mine for genes associ-
ated with Alzheimer disease. Compared to the Human Protein Reference Database (HPRD) PPI
network alone, the integrated HPRD PPI and GGCRN networks provided faster convergence and
revealed new disease-related genes. Therefore, using the RWR algorithm for integrated PPI and
GGCRN is an effective method for disease-associated gene mining.
 2015 The Authors. Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies. This
is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).1. Introduction
In humans, despite the rapid increase in the discovery of dis-
ease–associated genes, the molecular basis of many diseases is still
known. Even for diseases for which the molecular basis is partially
understood, a large proportion of the associated genes are still
unknown. The known disease-associated genes have been reported
to represent only a very small proportion of the actual number of
disease-associated genes [1,2]. Hence, mining for disease genes
remains important.
Network-based approaches to human disease have multiple
biological and clinical applications [3,4]. Many molecular networks
have been constructed experimentally to characterize the physicaland/or functional interactions between biomolecules [4,5]. There
are many methods for disease gene mining using molecular net-
works, such as the direct neighborhood [6–13], Shortest path
length [13–16], Diffusion kernel [8], random walk with restart
[8,9,17], propagation ﬂow [18], and clique backbone [19] methods.
The random walk with restart (RWR) method has been reported to
have the best performance in terms of precision and recall, while
both the random walk and propagation ﬂow methods are superior
to the clustering and neighborhood methods [20,21]. The most
useful network is the protein–protein interaction (PPI) network
[6,8,9]. Some other resources are also used in disease gene mining,
such as gene ontology, gene co-expression network, KEGG, struc-
ture, and TRANSFAC [7,10,15,16].
Expression quantitative trait loci (eQTLs) analyses of DNA use
hundreds of thousands of single-nucleotide polymorphism (SNP)
markers that capture human genetic variation [22]. This strategy
has been successfully applied to several diseases, such as celiac dis-
ease [23], asthma [24] and type 2 diabetes [25]. An eQTL is a locus
that regulates a gene expression phenotype [26]. If two genes are
regulated by one or more of the same SNPs, they are considered
to be co-regulated. Obviously, this co-regulation is only one type
of gene interactions. We constructed a gene–gene co-regulation
Fig. 1. The ﬂow chart of RWR method using the Union network.
252 J. Li et al. / FEBS Open Bio 5 (2015) 251–256network (GGCRN) using eQTL data and believe that it will be useful
for disease gene mining.
In this study, we developed a GGCRN, integrated it with the PPI
network, and used the RWR method to mine for candidate disease
genes. Using Alzheimer disease (AD) as an example, we demon-
strated that this newly developed GGCRN is an effective resource
for disease gene mining.
2. Materials and methods
2.1. Materials
2.1.1. Protein–protein interaction data
The Human Protein Reference Database (HPRD) describes inter-
action networks in the human proteome [27]. All information in
the HPRD has been manually extracted from the literature by
expert biologists who read, interpreted and analyzed the published
data. For this study, we used HPRD, release 9, which contains
38,989 protein–protein interactions among 9605 proteins.
2.1.2. EQTL data
We used human brain tissue data for this disease gene mining
study. The data were obtained from a series of 193 neuropathologi-
cally normal human brain samples using the Affymetrix GeneChip
Human Mapping 500 K Array Set and Illumina HumanRefseq-8
Expression BeadChip platforms [28]. The eQTLs were determined
by Matrix eQTL [29]. In this study, the cis-eQTL deﬁnition was a
SNP within the gene body +1 Mb up/down stream of the gene body.
We calculated cis-eQTLs and trans-eQTLs and performed FDR
adjustment (q value < 0.1) separately; then we combined the cis-
eQTLs and trans-eQTLs. Finally, we obtained 25,866 signiﬁcant
SNP-gene association pairs of 3709 genes. The results can be down-
loaded from the seeQTL database [30].
2.1.3. AD-related genes
Online Mendelian Inheritance in Man (OMIM) is a comprehen-
sive, authoritative compendium of human genes and genetic phe-
notypes that is freely available and updated daily. AD is classiﬁed
as a neurodegenerative disorder, and it is associated with plaques
and tangles in the brain [31]. We obtained 29 AD-related terms
from OMIM [32]. After removing the terms with no approved gene
symbol, we obtained 15 AD-related genes. Of these 15 genes, 14, 4
and 14 genes were present in the HPRD PPI, the GGCRN, and the
HPRD PPI and GGCRN integrated network (Union network). We
used the 14 genes that were present in the Union network for
the subsequent analyses. See Supplemental Table 1.
2.2. Methods
2.2.1. Gene–gene co-regulation network construction
The human brain data included 25,866 signiﬁcant SNP-gene
association pairs of 3709 genes. For each gene, we ﬁrst extracted
the SNPs that regulate it, and we called these signiﬁcant related
SNPs. If a SNP regulated two genes, we called it a common SNP
of the two genes. We considered two genes to be co-regulated if
a speciﬁc proportion of SNPs regulated both genes.
Mathematically, for any 2 genes (Gi and Gj), there are n1 and n2 sig-
niﬁcant related SNPs, respectively. The gene–gene co-regulation
coefﬁcient is deﬁned as
corecoðGi;GjÞ ¼ #ðSNPs in Gi \ SNPs in GjÞ
#ðSNPs in Gi [ SNPs in GjÞ ;
Where # (A) is the element number in set A. In other words,
#ðSNPs in Gi \ SNPs in GjÞ is the number of common SNPs that
regulate both gene Gi and Gj; and #ðSNPs in Gi [ SNPs in GjÞ isthe number of SNPs that regulate gene Gi or Gj. For example, if Gi
and Gj have 100 and 80 signiﬁcant related SNPs, respectively, and
30 of them are common SNPs for Gi and Gj, then the co-regulation
coefﬁcient is 30/(100 + 80  30) = 0.2. After calculating all co-reg-
ulation coefﬁcients for all gene pairs, a reasonable threshold value
for ﬁltering the signiﬁcant co-regulated gene pairs had to be estab-
lished; for this purpose, we used the clustering coefﬁcient differ-
ence maximization method [33]. The main function of this
method is the determination of the difference in the maximum
clustering coefﬁcient difference between a real network and a ran-
dom network if the real network is highly credible. Finally, we
obtained the GGCRN using the signiﬁcant co-regulated gene pairs.
2.2.2. Random walk with restart algorithm
In this paper, we focused on the genetic data resources rather
than on statistical methods. Therefore, we adopted a classic and
efﬁcient method. The random walk algorithm (RW) for graphs is
deﬁned as an iterative walker’s random transition from its current
node to a neighboring node, and this is initiated at a given source
node [34,35]. The random walk with restart algorithm (RWR) [36]
is a variant of the random walk that allows for the restart of the
walk at every time step at source node s with probability r.
Formally, the RWR is deﬁned as:
ptþ1 ¼ ð1 rÞWpt þ rp0
where W is the column-normalized adjacency matrix of the graph
and pt is a vector in which the ith element holds the probability
of being at node i at time step t. A special case is the initial proba-
bility vector, p0, which is the probability of being at source node, s.
In our application, p0 was constructed such that equal probabilities
were assigned to the known disease genes, with the sum of the
probabilities equal to 1. Genes were ranked according to the values
in the steady-state probability vector pN. This was obtained by per-
forming the iteration until the change between pt and pt+1 fell below
106. The results of RWR are affected by the restart probability, r.
We perform a numerical experiment to select the proper r value.
The ﬂow chart is illustrated in Fig. 1.
2.2.3. Direct neighborhood algorithm
We also compared the RWR method with the direct neighbor-
hood (DN) method. In the DN method, the interaction partners in
the network were determined for each known disease gene. The
more linkages that exist between a gene and known disease genes
for a particular disease, the greater the possibility that it is related
Table 1
Comparisons of the HPRD PPI and GGCRN networks.
Networks Number of
genes
Number of
gene pairs
Number of
AD genes
HPRD PPI 9605 39,023 14
GGCRN 1444 25,937 4
Intersection of HPRD and GGCRN 8 4 0
Union of HPRD and GGCRN 10,209 64,956 14
Table 2
Comparisons of the results of disease gene mining in 3 networks.
r HPRD PPI GGCRN Union network
0 5805 1440 7448
0.01 124 41 304
0.015 58 41 27
0.02 27 2 9
0.025 25 2 4
0.03 7 2 2
0.035 4 2 1
0.04 1 2 1
0.045 1 2 1
0.05 1 2 1
0.1 1 2 1
0.2 0 2 0
0.3 0 2 0
0.4–0.9 0 0 0
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known disease genes were considered candidate disease genes.
3. Results and discussion
3.1. Gene–gene co-regulation network
From the brain data, we identiﬁed 181,906 co-regulated gene
pairs of 2830 genes with nonzero co-regulation coefﬁcients. We
set the threshold to 0 to 1, a distance of 0.01. We calculated the
trends in the clustering coefﬁcients, and found the ﬁrst extreme
point of clustering coefﬁcient difference (the real clustering coefﬁ-
cient minus the background clustering coefﬁcient, Fig. 2). As a
result, we identiﬁed 25,937 gene pairs of 1444 genes under a
threshold value 0.63.
3.2. Comparison between HPRD and brain co-regulation network
The comparison of the HPRD PPI and GGCRN network revealed
only 4 common gene-gene pairs between 8 genes (Table 1). This
indicates that the gene–gene regulation patterns in the GGCRN
were different from the protein–protein interactions in the HPRD
PPI network. Therefore, the GGCRN can provide new information
about gene pairs.
In the following analysis, we used 3 networks, the HPRD PPI
network, the GGCRN and the Union network.
3.3. Disease gene mining
In the RWRmethod, to obtain a reasonable restart probability, r,
we performed a numerical experiment. First, we set r to 0, 0.1, 0.2,
0.3, 0.4, 0.5, 0.6, 0.7, 0.8 and 0.9. When r was 0, the RWR could not
reach steady state, so we added a stop condition of walking no
more than 100,000 times. To mine for disease risk genes, we
selected the genes with a steady-state probability greater than
the initial known disease genes and considered them candidate
genes. The results of this analysis are described in Table 2. We
found that when r was 0, we obtained too many candidate genes
and that when rwas more than 0.1, we obtained too few candidate
genes. Then, we set r to 0.01, 0.015, 0.02, 0.025, 0.03, 0.035, 0.04,
0.045 and 0.05. We did not know exactly how many disease genes
existed; thus we deﬁned a standard for mining risk genes of mining
less than 2 times of the known initial genes. For AD, we examined
14 initial genes in the HPRD PPI and Union networks and 4 initialFig. 2. The trends of the cgenes in the co-regulation network. Using the co-regulation net-
work, we obtained 41 candidate genes with r set at 0.015 and 2
candidate genes with r set at 0.02. As there were only 4 initial
genes, this was not a good result, and this is because the co-reg-
ulation network is small, only containing 1444 genes. Therefore,
it is unsuitable for candidate gene mining using only the GGCRN.
Then, we compared the results using the HPRD PPI and Union net-
work. With r set at 0.01, the numbers of candidate genes obtained
were still insufﬁcient. While, with an r value larger than 0.015, we
obtained more candidate genes using the HPRD PPI network than
the Union network with the same restart probability. In other
words, to obtain the same number of candidate genes using these
two networks, a higher restart probability is needed for the HPRD
PPI network than for the Union network. This indicates that more
convergent results can be obtained using the Union network than
the HPRD PPI network alone. Therefore, the GGCRN constructed
by eQTL data is a useful resource for mining disease genes.lustering coefﬁcients.
Table 3
The 10 candidate genes uncommon between the HPRD PPI and Union networks.
Genes Rank in the results of
HPRD
Rank in the results of Union
network
CTNNB1 23 28
RB1 24 36
TRAF2 25 30
AKT1 26 34
PIK3R1 27 37
RAF1 66 16
MCM2 423 20
RPS6KA1 476 24
MDM2 126 26
MAP3K3 547 27
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disease genes were considered candidate disease genes. In the co-
regulation network, there were only 4 initial known AD genes, and
no gene had more than 1 linkage with known disease genes. In the
HPRD PPI and Union networks, there were 14 initial known AD
genes, and there were 38 and 39 genes with more than 1 linkage
with known disease genes, respectively. These results show that
the co-regulation network is not suitable for gene mining by the
DN method, because it is too small. Furthermore, the results of
gene mining with DN method using the combination of the co-reg-
ulation network and the HPRD PPI network were almost the same
as those for the HPRD PPI network alone. The detailed results of
this analysis are shown in Supplemental Table 2.
For gene mining with the RWR method using the Union net-
work we obtained 27 candidate genes with r set at 0.015, and for
gene mining with the DN method using the Union network we
obtained 39 genes with more than 1 linkage with known disease
genes. Only 1 gene was common between these two gene sets.
Even when we included all genes that neighbored known AD genes
with the DN method, only 11 genes were common between these
two gene sets. These results show that the RWR method tends to
identify more indirect neighborhood genes, and this is consistent
with the gene function pattern of biological networks: genes that
interact indirectly may perform the same functions as those that
interact directly. Additionally, it was previously reported that the
RWR method has the best performance in terms of precision and
recall compared to other neighborhood methods [20,21].
3.4. Gene annotation
To test the usefulness of the candidate genes mined by RWR, we
compared them to those published in the literature. We ﬁrst veri-
ﬁed the 4 most likely AD risk genes (CP, EP300, TP53, and YWHAG,
with a restart probability 0.035 in the HPRD PPI and 0.025 in the
Union network). The protein encoded by CP is a metalloprotein
that binds most of the copper in plasma and is involved in the per-
oxidation of Fe(II) transferrin to Fe(III) transferrin. Mutations in
this gene cause aceruloplasminemia, which is associated with neu-
rologic abnormalities. Some studies conﬁrmed that ceruloplasmin
is increased in patients with AD [37,38]. EP300 encodes the aden-
ovirus E1A-associated cellular p300 transcriptional co-activator
protein, which mediates cAMP-gene regulation by binding speciﬁ-
cally to phosphorylated CREB protein and has been shown to be
related to AD [39,40]. TP53 (P53) encodes a tumor suppressor pro-
tein that contains transcriptional activation, DNA binding, and
oligomerization domains. TP53 is involved in neurodegenerative
syndromesis, and is up-regulated in AD [41–43]. YWHAG has been
shown to interact with RAF1 and protein kinase C and is involved
in various signal transduction pathways. A gene expression analy-
sis showed that YWHAG is down-regulated in AD [44]. These
results indicate that these 4 genes are related to AD with high
conﬁdence.
To compare between the results of gene mining using the HPRD
PPI and Union networks, we analyzed the 27 genes detected in the
HPRD PPI with r set at 0.02 and the 27 genes detected in the Union
network with r set at 0.015. The detailed results are shown in
Supplemental Table 3. Twenty-two genes were common between
the two networks, and they were in front of the 27 genes detected
in the HPRD PPI. We then analyzed the 10 genes that were uncom-
mon between the two networks, and we analyzed the ranks of
these genes in the results. The 5 genes that only appeared in the
results of the HPRD PPI network ranked from 28 to 37 in the results
of the Union network, which was just below the level of signiﬁ-
cance (rank 1–27). However, the 5 genes that only appeared in
the results of the Union network ranked from 66 to 547 in the
results of the HPRD PPI network. Thus, the 5 genes that onlyappeared in the results of the Union network are new discoveries
based on this gene–gene co-regulation information (Table 3).
We veriﬁed these 5 genes by comparison with those published
in the literature. RAF1 is the cellular homolog of the viral raf gene
(v-raf). It is one of the physiological activators of the ERK pathway,
which plays key roles in several steps of tumorigenesis, including
cancer cell proliferation, migration, and invasion [45]. Raf-1 activa-
tion effectively mediates Ras-dependent signals in AD [46]. The
protein encoded by MCM2 is one of the highly conserved mini-
chromosome maintenance proteins (MCM) that are involved in
the initiation of eukaryotic genome replication. Phosphorylated
MCM2 (pMCM2) is markedly associated with neuroﬁbrillary tan-
gles, neuropil threads, and dystrophic neurites in AD [47].
RPS6KA1 encodes a member of the RSK family of serine/threonine
kinases. This kinase contains 2 nonidentical kinase catalytic
domains and phosphorylates various substrates, including mem-
bers of the mitogen-activated kinase (MAPK) signaling pathway.
Deviation from the strict control of MAPK signaling pathways has
been implicated in the development of many human diseases,
including AD[45]. MDM2 encodes a nuclear-localized E3 ubiquitin
ligase. The encoded protein can promote tumor formation by tar-
geting tumor suppressor proteins, such as p53, for proteasomal
degradation. This gene is transcriptionally regulated by p53 [48],
which is involved in neurodegenerative syndromes, and is up regu-
lated in AD [41–43]. MAP3K3 (mitogen-activated protein kinase
kinase kinase 3) is a 626-amino acid polypeptide. This protein
directly regulates the stress-activated protein kinase (SAPK) and
extracellular signal-regulated protein kinase (ERK) pathways.
MAP3K3 phosphorylates RCAN1, and RCAN1-1L is overexpressed
in neurons in AD patients [49]. Furthermore, two polymorphisms
of the RCAN1 gene are associated with AD [50]. These results indi-
cated that these 5 genes are related to AD.
Compared with using the HPRD PPI network alone, more dis-
ease genes can be identiﬁed by integrating the HPRD PPI and
GGCRN networks. The results of this study indicate that eQTL-
based gene–gene regulation information is a useful resource for
disease gene mining.
4. Conclusion
There are certain relationships between genes that are associ-
ated with the same SNPs. The eQTL-based GGCRN developed here
provides extra gene–gene interaction information than the HPRD
PPI network. We integrated the GGCRN and HPRD PPI networks
and used the RWR method and DN method to mine for disease
gene candidates. The RWR method identiﬁed more indirect neigh-
borhood candidate genes than the DN method. Applying the AD
data, compared to using the HPRD PPI network, using the inte-
grated network obtained better results. With the same restart
probability, the integrated network provided faster convergence
and identiﬁed some new disease-related genes.
J. Li et al. / FEBS Open Bio 5 (2015) 251–256 255Therefore, disease gene mining using an RWR approach with an
integrated network (HPRD PPI and GGCRN) is an effective method.
This eQTL-based GGCRN also has some disadvantages such as its
coverage, the genes in this co-regulation network are not sufﬁcient.Author contribution statement
J.L. and M.G. conceived the study. J.L., L.W. and Q.D. did most of
the experiments. R.Z., X.L., C.W., Z.T., P.X. and M.Z. analyzed the
data. All authors reviewed the manuscript.
Acknowledgements
This work was supported in part by the National Natural
Science Foundation of China (61271346, 61300116, 61172098
and 91335112), Specialized Research Fund for the Doctoral
Program of Higher Education of China (20112302110040),
Fundamental Research Funds for the Central Universities
(HIT.KISTP.201418) and Natural Science Foundation of
Heilongjiang Province (QC2013C063).
Appendix A. Supplementary data
Supplementary data associated with this article can be found, in
the online version, at http://dx.doi.org/10.1016/j.fob.2015.03.011.
References
[1] Oldenburg, R.A., Meijers-Heijboer, H., Cornelisse, C.J. and Devilee, P. (2007)
Genetic susceptibility for breast cancer: how many more genes to be found?
Crit. Rev. Oncol. Hematol. 63, 125–149.
[2] Frayling, T.M. (2007) Genome-wide association studies provide new insights
into type 2 diabetes aetiology. Nat. Rev. Genet. 8, 657–662.
[3] Wang, X., Gulbahce, N. and Yu, H. (2011) Network-based methods for human
disease gene prediction. Brieﬁngs Funct. Genomics 10, 280–293.
[4] Barabasi, A.L., Gulbahce, N. and Loscalzo, J. (2011) Network medicine: a
network-based approach to human disease. Nat. Rev. Genet. 12, 56–68.
[5] Vidal, M., Cusick, M.E. and Barabasi, A.L. (2011) Interactome networks and
human disease. Cell 144, 986–998.
[6] Oti, M., Snel, B., Huynen, M.A. and Brunner, H.G. (2006) Predicting disease
genes using protein–protein interactions. J. Med. Genet. 43, 691–698.
[7] Aerts, S., Lambrechts, D., Maity, S., Van Loo, P., Coessens, B., De Smet, F.,
Tranchevent, L.C., De Moor, B., Marynen, P., Hassan, B., Carmeliet, P. and
Moreau, Y. (2006) Gene prioritization through genomic data fusion. Nat.
Biotechnol. 24, 537–544.
[8] Kohler, S., Bauer, S., Horn, D. and Robinson, P.N. (2008) Walking the
interactome for prioritization of candidate disease genes. Am. J. Hum. Genet.
82, 949–958.
[9] Navlakha, S. and Kingsford, C. (2010) The power of protein interaction
networks for associating genes with diseases. Bioinformatics 26, 1057–1063.
[10] Linghu, B., Snitkin, E.S., Hu, Z., Xia, Y. and Delisi, C. (2009) Genome-wide
prioritization of disease genes and identiﬁcation of disease–disease
associations from an integrated human functional linkage network. Genome
Biol. 10, R91.
[11] Lage, K., Karlberg, E.O., Storling, Z.M., Olason, P.I., Pedersen, A.G., Rigina, O.,
Hinsby, A.M., Tumer, Z., Pociot, F., Tommerup, N., Moreau, Y. and Brunak, S.
(2007) A human phenome–interactome network of protein complexes
implicated in genetic disorders. Nat. Biotechnol. 25, 309–316.
[12] Care, M.A., Bradford, J.R., Needham, C.J., Bulpitt, A.J. and Westhead, D.R. (2009)
Combining the interactome and deleterious SNP predictions to improve
disease gene identiﬁcation. Hum. Mutat. 30, 485–492.
[13] Wu, X., Jiang, R., Zhang, M.Q. and Li, S. (2008) Network-based global inference
of human disease genes. Mol. Syst. Biol. 4, 189.
[14] Radivojac, P., Peng, K., Clark, W.T., Peters, B.J., Mohan, A., Boyle, S.M. and
Mooney, S.D. (2008) An integrated approach to inferring gene–disease
associations in humans. Proteins 72, 1030–1037.
[15] Franke, L., van Bakel, H., Fokkens, L., de Jong, E.D., Egmont-Petersen, M. and
Wijmenga, C. (2006) Reconstruction of a functional human gene network,
with an application for prioritizing positional candidate genes. Am. J. Hum.
Genet. 78, 1011–1025.
[16] Karni, S., Soreq, H. and Sharan, R. (2009) A network-based method for
predicting disease-causing genes. J. Comput. Biol. 16, 181–189.
[17] Li, Y. and Patra, J.C. (2010) Genome-wide inferring gene–phenotype
relationship by walking on the heterogeneous network. Bioinformatics 26,
1219–1224.[18] Vanunu, O., Magger, O., Ruppin, E., Shlomi, T. and Sharan, R. (2010) Associating
genes and protein complexes with disease via network propagation. PLoS
Comput. Biol. 6, e1000641.
[19] Yang, L., Zhao, X. and Tang, X. (2014) Predicting disease-related proteins based
on clique backbone in protein–protein interaction network. Int. J. Biol. Sci. 10,
677–688.
[20] Brown, K.R. and Jurisica, I. (2005) Online predicted human interaction
database. Bioinformatics 21, 2076–2082.
[21] Jain, E., Bairoch, A., Duvaud, S., Phan, I., Redaschi, N., Suzek, B.E., Martin, M.J.,
McGarvey, P. and Gasteiger, E. (2009) Infrastructure for the life sciences:
design and implementation of the UniProt website. BMC Bioinf. 10, 136.
[22] Franke, L. and Jansen, R.C. (2009) EQTL analysis in humans. Methods Mol. Biol.
573, 311–328.
[23] Hunt, K.A., Zhernakova, A., Turner, G., Heap, G.A., Franke, L., Bruinenberg, M.,
Romanos, J., Dinesen, L.C., Ryan, A.W., Panesar, D., Gwilliam, R., Takeuchi, F.,
McLaren, W.M., Holmes, G.K., Howdle, P.D., Walters, J.R., Sanders, D.S.,
Playford, R.J., Trynka, G., Mulder, C.J., Mearin, M.L., Verbeek, W.H., Trimble,
V., Stevens, F.M., O’Morain, C., Kennedy, N.P., Kelleher, D., Pennington, D.J.,
Strachan, D.P., McArdle, W.L., Mein, C.A., Wapenaar, M.C., Deloukas, P.,
McGinnis, R., McManus, R., Wijmenga, C. and van Heel, D.A. (2008) Newly
identiﬁed genetic risk variants for celiac disease related to the immune
response. Nat. Genet. 40, 395–402.
[24] Moffatt, M.F., Kabesch, M., Liang, L., Dixon, A.L., Strachan, D., Heath, S., Depner,
M., von Berg, A., Bufe, A., Rietschel, E., Heinzmann, A., Simma, B., Frischer, T.,
Willis-Owen, S.A., Wong, K.C., Illig, T., Vogelberg, C., Weiland, S.K., von Mutius,
E., Abecasis, G.R., Farrall, M., Gut, I.G., Lathrop, G.M. and Cookson, W.O. (2007)
Genetic variants regulating ORMDL3 expression contribute to the risk of
childhood asthma. Nature 448, 470–473.
[25] Das, S.K. and Sharma, N.K. (2014) Expression quantitative trait analyses to
identify causal genetic variants for type 2 diabetes susceptibility. World J.
Diabetes 5, 97–114.
[26] Nica, A.C. and Dermitzakis, E.T. (2013) Expression quantitative trait loci:
present and future. Philos. Trans. R. Soc. Lond. Ser. B, Biol. Sci. 368, 20120362.
[27] Keshava Prasad, T.S., Goel, R., Kandasamy, K., Keerthikumar, S., Kumar, S.,
Mathivanan, S., Telikicherla, D., Raju, R., Shafreen, B., Venugopal, A.,
Balakrishnan, L., Marimuthu, A., Banerjee, S., Somanathan, D.S., Sebastian, A.,
Rani, S., Ray, S., Harrys Kishore, C.J., Kanth, S., Ahmed, M., Kashyap, M.K.,
Mohmood, R., Ramachandra, Y.L., Krishna, V., Rahiman, B.A., Mohan, S.,
Ranganathan, P., Ramabadran, S., Chaerkady, R. and Pandey, A. (2009) Human
Protein Reference Database – 2009 update. Nucleic Acids Res. 37, D767–D772.
[28] Myers, A.J., Gibbs, J.R., Webster, J.A., Rohrer, K., Zhao, A., Marlowe, L., Kaleem,
M., Leung, D., Bryden, L., Nath, P., Zismann, V.L., Joshipura, K., Huentelman,
M.J., Hu-Lince, D., Coon, K.D., Craig, D.W., Pearson, J.V., Holmans, P., Heward,
C.B., Reiman, E.M., Stephan, D. and Hardy, J. (2007) A survey of genetic human
cortical gene expression. Nat. Genet. 39, 1494–1499.
[29] Shabalin, A.A. (2012) Matrix eQTL: ultra fast eQTL analysis via large matrix
operations. Bioinformatics 28, 1353–1358.
[30] Xia, K., Shabalin, A.A., Huang, S., Madar, V., Zhou, Y.H., Wang, W., Zou, F., Sun,
W., Sullivan, P.F. and Wright, F.A. (2012) SeeQTL: a searchable database for
human eQTLs. Bioinformatics 28, 451–452.
[31] Tiraboschi, P., Hansen, L.A., Thal, L.J. and Corey-Bloom, J. (2004) The
importance of neuritic plaques and tangles to the development and
evolution of AD. Neurology 62, 1984–1989.
[32] Hamosh, A., Scott, A.F., Amberger, J.S., Bocchini, C.A. and McKusick, V.A. (2005)
Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human
genes and genetic disorders. Nucleic Acids Res. 33, D514–D517.
[33] Elo, L.L., Jarvenpaa, H., Oresic, M., Lahesmaa, R. and Aittokallio, T. (2007)
Systematic construction of gene coexpression networks with applications to
human T helper cell differentiation process. Bioinformatics 23, 2096–2103.
[34] Pearson, K. (1905) The problem of the random walk. Nature 72, 1.
[35] Lange, K. and Sobel, E. (1991) A random walk method for computing genetic
location scores. Am. J. Hum. Genet. 49, 1320–1334.
[36] Ham, B., Min, D. and Sohn, K. (2013) A generalized random walk with restart
and its application in depth up-sampling and interactive segmentation. IEEE
Trans. Image Process. 22, 2574–2588.
[37] Connor, J.R., Tucker, P., Johnson, M. and Snyder, B. (1993) Ceruloplasmin levels
in the human superior temporal gyrus in aging and Alzheimer’s disease.
Neurosci. Lett. 159, 88–90.
[38] Squitti, R., Pasqualetti, P., Dal Forno, G., Moffa, F., Cassetta, E., Lupoi, D.,
Vernieri, F., Rossi, L., Baldassini, M. and Rossini, P.M. (2005) Excess of serum
copper not related to ceruloplasmin in Alzheimer disease. Neurology 64,
1040–1046.
[39] Saura, C.A. and Valero, J. (2011) The role of CREB signaling in Alzheimer’s
disease and other cognitive disorders. Rev. Neurosci. 22, 153–169.
[40] Urdinguio, R.G., Sanchez-Mut, J.V. and Esteller, M. (2009) Epigenetic
mechanisms in neurological diseases: genes, syndromes, and therapies.
Lancet Neurol. 8, 1056–1072.
[41] Hooper, C., Meimaridou, E., Tavassoli, M., Melino, G., Lovestone, S. and Killick,
R. (2007) P53 is upregulated in Alzheimer’s disease and induces tau
phosphorylation in HEK293a cells. Neurosci. Lett. 418, 34–37.
[42] Kitamura, Y., Shimohama, S., Kamoshima, W., Matsuoka, Y., Nomura, Y. and
Taniguchi, T. (1997) Changes of p53 in the brains of patients with Alzheimer’s
disease. Biochem. Biophys. Res. Commun. 232, 418–421.
[43] Vousden, K.H. and Lane, D.P. (2007) P53 in health and disease. Nat. Rev. Mol.
Cell Biol. 8, 275–283.
256 J. Li et al. / FEBS Open Bio 5 (2015) 251–256[44] Hokama, M., Oka, S., Leon, J., Ninomiya, T., Honda, H., Sasaki, K., Iwaki, T.,
Ohara, T., Sasaki, T., Laferla, F.M., Kiyohara, Y. and Nakabeppu, Y. (2014)
Altered expression of diabetes-related genes in Alzheimer’s disease brains: the
Hisayama study. Cereb. Cortex 24 (9), 2476–2488, http://dx.doi.org/10.1093/
cercor/bht101.
[45] Kim, E.K. and Choi, E.J. (2010) Pathological roles of MAPK signaling pathways
in human diseases. Biochim. Biophys. Acta 1802, 396–405.
[46] Mei, M., Su, B., Harrison, K., Chao, M., Siedlak, S.L., Previll, L.A., Jackson, L., Cai,
D.X. and Zhu, X. (2006) Distribution, levels and phosphorylation of Raf-1 in
Alzheimer’s disease. J. Neurochem. 99, 1377–1388.
[47] Bonda, D.J., Evans, T.A., Santocanale, C., Llosa, J.C., Vina, J., Bajic, V., Castellani,
R.J., Siedlak, S.L., Perry, G., Smith, M.A. and Lee, H.G. (2009) Evidence for theprogression through S-phase in the ectopic cell cycle re-entry of neurons in
Alzheimer disease. Aging 1, 382–388.
[48] Picksley, S.M. and Lane, D.P. (1993) The p53-mdm2 autoregulatory feedback
loop: a paradigm for the regulation of growth control by p53? Bioessays 15,
689–690.
[49] Harris, C.D., Ermak, G. and Davies, K.J. (2007) RCAN1-1L is overexpressed in
neurons of Alzheimer’s disease patients. FEBS J. 274, 1715–1724.
[50] Lin, K.G., Tang, M., Guo, Y.B., Han, H.Y. and Lin, Y.H. (2011) Two
polymorphisms of RCAN1 gene associated with Alzheimer’s disease in the
Chinese Han population. East Asian Arch. Psychiatry 21, 79–84.
